External beam radiotherapy and intracavitary brachytherapy is an acceptable treatment for locally advanced carcinoma of the uterine cervix

Background: Cervical carcinoma is the second most common neoplasm in women worldwide and is the most frequent cancer among women in Bangladesh. In recent years, High Dose Rate (HDR) brachytherapy in combination with External Beam Radiotherapy (EBRT) has been popular in the management of cancers of u...

Full description

Bibliographic Details
Main Authors: Md. Zillur Rahman Bhuiyan, Atiar Rahman, Sarwar Alam, Sheikh Saiful Islam Shaheen, Md. Ashadul lslam, S. K. Golam Mostafa
Format: Article
Language:English
Published: Bangabandhu Sheikh Mujib Medical University 2016-08-01
Series:Bangabandhu Sheikh Mujib Medical University Journal
Subjects:
Online Access:https://www.banglajol.info/index.php/BSMMUJ/article/view/29143
_version_ 1811330064612065280
author Md. Zillur Rahman Bhuiyan
Atiar Rahman
Sarwar Alam
Sheikh Saiful Islam Shaheen
Md. Ashadul lslam
S. K. Golam Mostafa
author_facet Md. Zillur Rahman Bhuiyan
Atiar Rahman
Sarwar Alam
Sheikh Saiful Islam Shaheen
Md. Ashadul lslam
S. K. Golam Mostafa
author_sort Md. Zillur Rahman Bhuiyan
collection DOAJ
description Background: Cervical carcinoma is the second most common neoplasm in women worldwide and is the most frequent cancer among women in Bangladesh. In recent years, High Dose Rate (HDR) brachytherapy in combination with External Beam Radiotherapy (EBRT) has been popular in the management of cancers of uterine cervix. Objectives: To evaluate the effectiveness and acute toxicity of four fractions high dose rate intracavitary brachytherapy following pelvic external beam radiotherapy in the treatment of locally advanced cervical carcinoma. Methods: Bangabandhu Sheikh Mujib Medi­cal University & NICRH chosen as a research place for EBRT and HOR brachytherapy. A typical radiotherapy treatment involves daily inadiation for several weeks. Whole pelvis was treated with total dose of SO Gy in 5 weeks. Patients were treated once a day, 5 days a week with a daily fraction size of 2.0 Gy. EBRT: Pelvic radiotherapy dose is 50 Gy in 25 fractions (2.0 Gy per fraction) over 5 weeks. HDR brachytberapy dose is 7 Gy per fraction, total 4 fractions, each in a week over 4 weeks. Results: Ninety-eight patients were entered in the study. Three patients were excluded due to active non-malignant diseases. One patient had active tuberculosis, two patients had severe skin reactions and two patients withdrew following the first HDR application. The remaining Ninety patients were analyzed. Ninety patients completed the prescribed treatment and were evaluated. Eighty had complete response with relief of symptoms, negative Pap-smear and no clinical signs of persistence disease at 3 months. Ten patients had a positive Pap-smear with clinical signs of persis­tence disease. Patients were evaluated before statting treatment with EBRT and before starting treatment with HDR ICBT. Conclusion: It can be easily concluded that 4 fractions of HDR ICBT, 7 Gy each weekly and pelvic EBRT can effectively and safely control locally advanced carcinoma of the uterine cervix. So that EBRT and HDR ICBT is an acceptable treatment for locally advanced carcinoma of the uterine cervix. Careful attention to normal tissue doses such as the rectum, bladder, and small bowel is important in the treatment of locally advanced cervical cancer.
first_indexed 2024-04-13T15:56:02Z
format Article
id doaj.art-2b7055b22f9146a29abd3a88225c134b
institution Directory Open Access Journal
issn 2074-2908
2224-7750
language English
last_indexed 2024-04-13T15:56:02Z
publishDate 2016-08-01
publisher Bangabandhu Sheikh Mujib Medical University
record_format Article
series Bangabandhu Sheikh Mujib Medical University Journal
spelling doaj.art-2b7055b22f9146a29abd3a88225c134b2022-12-22T02:40:42ZengBangabandhu Sheikh Mujib Medical UniversityBangabandhu Sheikh Mujib Medical University Journal2074-29082224-77502016-08-017110.3329/bsmmuj.v7i1.2914318740External beam radiotherapy and intracavitary brachytherapy is an acceptable treatment for locally advanced carcinoma of the uterine cervixMd. Zillur Rahman Bhuiyan0Atiar Rahman1Sarwar Alam2Sheikh Saiful Islam Shaheen3Md. Ashadul lslam4S. K. Golam Mostafa5Department of Oncology, Bangabandhu Sheikh Mujib Medical University, Kazi Nazrul Islam Avenue, Shahbag, DhakaDepartment of Transfusion Medicine, Bangabandhu Sheikh Mujib Medical University, Kazi Nazrul Islam Avenue, Shahbag, DhakaDepartment of Oncology, Bangabandhu Sheikh Mujib Medical University, Kazi Nazrul Islam Avenue, Shahbag, DhakaDepartment of Transfusion Medicine, Bangabandhu Sheikh Mujib Medical University, Kazi Nazrul Islam Avenue, Shahbag, DhakaDepartment of Transfusion Medicine, Bangabandhu Sheikh Mujib Medical University, Kazi Nazrul Islam Avenue, Shahbag, DhakaDepartment of Transfusion Medicine, National Institute of Cancer ResearchBackground: Cervical carcinoma is the second most common neoplasm in women worldwide and is the most frequent cancer among women in Bangladesh. In recent years, High Dose Rate (HDR) brachytherapy in combination with External Beam Radiotherapy (EBRT) has been popular in the management of cancers of uterine cervix. Objectives: To evaluate the effectiveness and acute toxicity of four fractions high dose rate intracavitary brachytherapy following pelvic external beam radiotherapy in the treatment of locally advanced cervical carcinoma. Methods: Bangabandhu Sheikh Mujib Medi­cal University & NICRH chosen as a research place for EBRT and HOR brachytherapy. A typical radiotherapy treatment involves daily inadiation for several weeks. Whole pelvis was treated with total dose of SO Gy in 5 weeks. Patients were treated once a day, 5 days a week with a daily fraction size of 2.0 Gy. EBRT: Pelvic radiotherapy dose is 50 Gy in 25 fractions (2.0 Gy per fraction) over 5 weeks. HDR brachytberapy dose is 7 Gy per fraction, total 4 fractions, each in a week over 4 weeks. Results: Ninety-eight patients were entered in the study. Three patients were excluded due to active non-malignant diseases. One patient had active tuberculosis, two patients had severe skin reactions and two patients withdrew following the first HDR application. The remaining Ninety patients were analyzed. Ninety patients completed the prescribed treatment and were evaluated. Eighty had complete response with relief of symptoms, negative Pap-smear and no clinical signs of persistence disease at 3 months. Ten patients had a positive Pap-smear with clinical signs of persis­tence disease. Patients were evaluated before statting treatment with EBRT and before starting treatment with HDR ICBT. Conclusion: It can be easily concluded that 4 fractions of HDR ICBT, 7 Gy each weekly and pelvic EBRT can effectively and safely control locally advanced carcinoma of the uterine cervix. So that EBRT and HDR ICBT is an acceptable treatment for locally advanced carcinoma of the uterine cervix. Careful attention to normal tissue doses such as the rectum, bladder, and small bowel is important in the treatment of locally advanced cervical cancer.https://www.banglajol.info/index.php/BSMMUJ/article/view/29143Beam radiotherapyBrachytherapyCarcinomaUterine cervix
spellingShingle Md. Zillur Rahman Bhuiyan
Atiar Rahman
Sarwar Alam
Sheikh Saiful Islam Shaheen
Md. Ashadul lslam
S. K. Golam Mostafa
External beam radiotherapy and intracavitary brachytherapy is an acceptable treatment for locally advanced carcinoma of the uterine cervix
Bangabandhu Sheikh Mujib Medical University Journal
Beam radiotherapy
Brachytherapy
Carcinoma
Uterine cervix
title External beam radiotherapy and intracavitary brachytherapy is an acceptable treatment for locally advanced carcinoma of the uterine cervix
title_full External beam radiotherapy and intracavitary brachytherapy is an acceptable treatment for locally advanced carcinoma of the uterine cervix
title_fullStr External beam radiotherapy and intracavitary brachytherapy is an acceptable treatment for locally advanced carcinoma of the uterine cervix
title_full_unstemmed External beam radiotherapy and intracavitary brachytherapy is an acceptable treatment for locally advanced carcinoma of the uterine cervix
title_short External beam radiotherapy and intracavitary brachytherapy is an acceptable treatment for locally advanced carcinoma of the uterine cervix
title_sort external beam radiotherapy and intracavitary brachytherapy is an acceptable treatment for locally advanced carcinoma of the uterine cervix
topic Beam radiotherapy
Brachytherapy
Carcinoma
Uterine cervix
url https://www.banglajol.info/index.php/BSMMUJ/article/view/29143
work_keys_str_mv AT mdzillurrahmanbhuiyan externalbeamradiotherapyandintracavitarybrachytherapyisanacceptabletreatmentforlocallyadvancedcarcinomaoftheuterinecervix
AT atiarrahman externalbeamradiotherapyandintracavitarybrachytherapyisanacceptabletreatmentforlocallyadvancedcarcinomaoftheuterinecervix
AT sarwaralam externalbeamradiotherapyandintracavitarybrachytherapyisanacceptabletreatmentforlocallyadvancedcarcinomaoftheuterinecervix
AT sheikhsaifulislamshaheen externalbeamradiotherapyandintracavitarybrachytherapyisanacceptabletreatmentforlocallyadvancedcarcinomaoftheuterinecervix
AT mdashadullslam externalbeamradiotherapyandintracavitarybrachytherapyisanacceptabletreatmentforlocallyadvancedcarcinomaoftheuterinecervix
AT skgolammostafa externalbeamradiotherapyandintracavitarybrachytherapyisanacceptabletreatmentforlocallyadvancedcarcinomaoftheuterinecervix